Annual CFF
-$79.00 K
-$113.00 K-332.35%
31 December 2023
Summary:
Nephros annual cash flow from financing activities is currently -$79.00 thousand, with the most recent change of -$113.00 thousand (-332.35%) on 31 December 2023. During the last 3 years, it has fallen by -$11.29 million (-100.70%). NEPH annual CFF is now -100.55% below its all-time high of $14.28 million, reached on 31 December 2004.NEPH Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$0.00
+$2000.00+100.00%
01 September 2024
Summary:
Nephros quarterly cash flow from financing activities is currently $0.00, with the most recent change of +$2000.00 (+100.00%) on 01 September 2024. Over the past year, it has stayed the same.NEPH quarterly CFF is now -100.00% below its all-time high of $11.69 million, reached on 30 September 2007.NEPH Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$7000.00
$0.000.00%
01 September 2024
Summary:
Nephros TTM cash flow from financing activities is currently -$7000.00, unchanged on 01 September 2024. Over the past year, it has increased by +$180.00 thousand (+96.26%). NEPH TTM CFF is now -100.06% below its all-time high of $12.68 million, reached on 31 December 2007.NEPH TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEPH Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -332.4% | 0.0% | +96.3% |
| 3 y3 years | -100.7% | -100.0% | -100.1% |
| 5 y5 years | -101.1% | -100.0% | -100.3% |
NEPH Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.7% | at low | -100.0% | +100.0% | -100.1% | +97.8% |
| 5 y | 5 years | -100.7% | at low | -100.0% | +100.0% | -100.1% | +97.8% |
| alltime | all time | -100.5% | at low | -100.0% | +100.0% | -100.1% | +97.8% |
Nephros Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(-100.0%) | -$7000.00(0.0%) |
| June 2024 | - | -$2000.00(0.0%) | -$7000.00(0.0%) |
| Mar 2024 | - | -$2000.00(-33.3%) | -$7000.00(-91.1%) |
| Dec 2023 | -$79.00 K(-332.4%) | -$3000.00(<-9900.0%) | -$79.00 K(-57.8%) |
| Sept 2023 | - | $0.00(-100.0%) | -$187.00 K(-27.0%) |
| June 2023 | - | -$2000.00(-97.3%) | -$256.00 K(-20.2%) |
| Mar 2023 | - | -$74.00 K(-33.3%) | -$321.00 K(-1044.1%) |
| Dec 2022 | $34.00 K(-85.7%) | -$111.00 K(+60.9%) | $34.00 K(-68.5%) |
| Sept 2022 | - | -$69.00 K(+3.0%) | $108.00 K(-51.6%) |
| June 2022 | - | -$67.00 K(-123.8%) | $223.00 K(-57.2%) |
| Mar 2022 | - | $281.00 K(-859.5%) | $521.00 K(+119.8%) |
| Dec 2021 | $237.00 K(-97.9%) | -$37.00 K(-180.4%) | $237.00 K(-95.2%) |
| Sept 2021 | - | $46.00 K(-80.1%) | $4.89 M(+2.3%) |
| June 2021 | - | $231.00 K(-7800.0%) | $4.78 M(+4.4%) |
| Mar 2021 | - | -$3000.00(-100.1%) | $4.58 M(-59.2%) |
| Dec 2020 | $11.22 M(+456.1%) | $4.62 M(-7200.0%) | $11.22 M(+71.3%) |
| Sept 2020 | - | -$65.00 K(-332.1%) | $6.55 M(-3.5%) |
| June 2020 | - | $28.00 K(-99.6%) | $6.78 M(-22.9%) |
| Mar 2020 | - | $6.64 M(<-9900.0%) | $8.79 M(+335.9%) |
| Dec 2019 | $2.02 M(-71.4%) | -$55.00 K(-132.2%) | $2.02 M(-29.2%) |
| Sept 2019 | - | $171.00 K(-91.6%) | $2.85 M(-49.5%) |
| June 2019 | - | $2.04 M(-1587.6%) | $5.64 M(-14.8%) |
| Mar 2019 | - | -$137.00 K(-117.6%) | $6.62 M(-6.1%) |
| Dec 2018 | $7.05 M(+254.1%) | $778.00 K(-73.7%) | $7.05 M(+8.1%) |
| Sept 2018 | - | $2.96 M(-1.9%) | $6.52 M(+58.2%) |
| June 2018 | - | $3.02 M(+929.4%) | $4.12 M(+275.9%) |
| Mar 2018 | - | $293.00 K(+18.1%) | $1.10 M(-44.9%) |
| Dec 2017 | $1.99 M(+67.5%) | $248.00 K(-56.0%) | $1.99 M(+14.2%) |
| Sept 2017 | - | $563.00 K(-7137.5%) | $1.74 M(+47.8%) |
| June 2017 | - | -$8000.00(-100.7%) | $1.18 M(-50.3%) |
| Mar 2017 | - | $1.19 M(>+9900.0%) | $2.37 M(+99.8%) |
| Dec 2016 | $1.19 M(-68.7%) | $0.00(0.0%) | $1.19 M(-36.7%) |
| Sept 2016 | - | $0.00(-100.0%) | $1.88 M(-50.3%) |
| June 2016 | - | $1.19 M(>+9900.0%) | $3.77 M(-0.5%) |
| Mar 2016 | - | $1000.00(-99.9%) | $3.79 M(0.0%) |
| Dec 2015 | $3.79 M(+18.4%) | $689.00 K(-63.7%) | $3.79 M(-9.1%) |
| Sept 2015 | - | $1.90 M(+57.3%) | $4.17 M(+7.1%) |
| June 2015 | - | $1.21 M(>+9900.0%) | $3.89 M(+44.9%) |
| Mar 2015 | - | $1000.00(-99.9%) | $2.69 M(-16.1%) |
| Dec 2014 | $3.20 M | $1.07 M(-34.0%) | $3.20 M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $1.62 M(<-9900.0%) | $3.44 M(+88.0%) |
| June 2014 | - | -$2000.00(-100.4%) | $1.83 M(-47.9%) |
| Mar 2014 | - | $517.00 K(-60.4%) | $3.51 M(-14.8%) |
| Dec 2013 | $4.12 M(+719.1%) | $1.30 M(>+9900.0%) | $4.12 M(+43.7%) |
| Sept 2013 | - | $9000.00(-99.5%) | $2.87 M(-2.9%) |
| June 2013 | - | $1.68 M(+49.2%) | $2.95 M(+88.9%) |
| Mar 2013 | - | $1.13 M(+2065.4%) | $1.56 M(+210.7%) |
| Dec 2012 | $503.00 K(-81.5%) | $52.00 K(-45.3%) | $503.00 K(-19.4%) |
| Sept 2012 | - | $95.00 K(-67.2%) | $624.00 K(+18.0%) |
| June 2012 | - | $290.00 K(+339.4%) | $529.00 K(+121.3%) |
| Mar 2012 | - | $66.00 K(-61.8%) | $239.00 K(-91.2%) |
| Dec 2011 | $2.72 M(+376.0%) | $173.00 K(>+9900.0%) | $2.72 M(-10.7%) |
| Sept 2011 | - | $0.00(0.0%) | $3.05 M(0.0%) |
| June 2011 | - | $0.00(-100.0%) | $3.05 M(-2.3%) |
| Mar 2011 | - | $2.55 M(+410.0%) | $3.12 M(+445.8%) |
| Dec 2010 | $572.00 K(-57.2%) | $500.00 K(>+9900.0%) | $572.00 K(+683.6%) |
| Sept 2010 | - | $0.00(-100.0%) | $73.00 K(-94.8%) |
| June 2010 | - | $72.00 K(>+9900.0%) | $1.41 M(+5.4%) |
| Mar 2010 | - | $0.00(-100.0%) | $1.34 M(0.0%) |
| Dec 2009 | $1.34 M(>+9900.0%) | $1000.00(-99.9%) | $1.34 M(+0.1%) |
| Sept 2009 | - | $1.33 M(>+9900.0%) | $1.33 M(>+9900.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2008 | - | $0.00(0.0%) | $992.00 K(-92.2%) |
| June 2008 | - | $0.00(0.0%) | $12.68 M(0.0%) |
| Mar 2008 | - | $0.00(-100.0%) | $12.68 M(0.0%) |
| Dec 2007 | $12.68 M(+143.7%) | $992.00 K(-91.5%) | $12.68 M(+8.6%) |
| Sept 2007 | - | $11.69 M(>+9900.0%) | $11.68 M(>+9900.0%) |
| June 2007 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2007 | - | $0.00(-100.0%) | $5.20 M(-0.0%) |
| Dec 2006 | $5.20 M(+418.6%) | -$7000.00(-200.0%) | $5.20 M(-0.2%) |
| Sept 2006 | - | $7000.00(-99.9%) | $5.21 M(+0.1%) |
| June 2006 | - | $5.20 M(>+9900.0%) | $5.20 M(>+9900.0%) |
| Mar 2006 | - | $1000.00(-28.6%) | $3800.00(-99.6%) |
| Dec 2005 | $1.00 M(-93.0%) | $1400.00(0.0%) | $1.00 M(+0.1%) |
| Sept 2005 | - | $1400.00(>+9900.0%) | $1.00 M(+0.1%) |
| June 2005 | - | $0.00(-100.0%) | $999.90 K(0.0%) |
| Mar 2005 | - | $999.90 K | $999.90 K |
| Dec 2004 | $14.28 M(+86.8%) | - | - |
| Dec 2003 | $7.65 M(+324.8%) | - | - |
| Dec 2002 | $1.80 M | - | - |
FAQ
- What is Nephros annual cash flow from financing activities?
- What is the all time high annual CFF for Nephros?
- What is Nephros annual CFF year-on-year change?
- What is Nephros quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Nephros?
- What is Nephros quarterly CFF year-on-year change?
- What is Nephros TTM cash flow from financing activities?
- What is the all time high TTM CFF for Nephros?
- What is Nephros TTM CFF year-on-year change?
What is Nephros annual cash flow from financing activities?
The current annual CFF of NEPH is -$79.00 K
What is the all time high annual CFF for Nephros?
Nephros all-time high annual cash flow from financing activities is $14.28 M
What is Nephros annual CFF year-on-year change?
Over the past year, NEPH annual cash flow from financing activities has changed by -$113.00 K (-332.35%)
What is Nephros quarterly cash flow from financing activities?
The current quarterly CFF of NEPH is $0.00
What is the all time high quarterly CFF for Nephros?
Nephros all-time high quarterly cash flow from financing activities is $11.69 M
What is Nephros quarterly CFF year-on-year change?
Over the past year, NEPH quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Nephros TTM cash flow from financing activities?
The current TTM CFF of NEPH is -$7000.00
What is the all time high TTM CFF for Nephros?
Nephros all-time high TTM cash flow from financing activities is $12.68 M
What is Nephros TTM CFF year-on-year change?
Over the past year, NEPH TTM cash flow from financing activities has changed by +$180.00 K (+96.26%)